MCAM and acute lymphoblastic leukemia: Conversely, 66% of T-ALL and 36.8% of the total B-ALL cases, comprising cases bearing the t(9;22)(q34;q11)/BCR/ABL translocation, expressed CD146 on their blasts [20].